ArticleEuropean journal of nuclear medicine and molecular imaging2026
Evaluating chronic bone and soft tissue infections with [
Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeChronic bone and soft tissue infections pose a diagnostic challenge, as conventional imaging techniques often show limited sensitivity and specificity. Given that CXCR4 chemokine receptors are expressed on lymphocytes, key mediators of chronic inflammatory response, we hypothesized that CXCR4-targeted imaging may offer enhanced diagnostic accuracy. Accordingly, this study aimed to evaluate the diagnostic performance of [
methodsIn this retrospective single-centre study, we included patients who underwent both conventional scintigraphic imaging and [
resultsA total of 20 patients with 25 suspected infectious foci and 14 control sites were evaluated. Of the 25 sites, 21 were confirmed to be infected; no infections were observed in the control sites. Scintigraphy correctly identified 19 infection sites (sensitivity: 90%, specificity: 83%), while [
conclusion[
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.